Facebook IconTwitter IconYouTube IconInstagram Icon

Press Releases

20

January 2022

AC Health boosts ‘Resbakuna sa Botika’ for qualified citizens at select Generika, Healthway, and QualiMed branches

Generika Drugstore, a member of AC Health, kicks off the group’s participation in the “Resbakuna sa Botika” pilot in their Signal Village branch in Taguig City. Present during the event is Sec. Vince Dizon, Presidential Adviser for COVID-19 Response.   

MANILA — Ayala Healthcare Holdings, Inc. (AC Health) is opening its doors to priority groups during the week-long pilot of the “Resbakuna sa Botika” program of the National Task Force Against COVID-19 beginning Thursday, January 20.

Generika Drugstore’s branch in Signal Village, Taguig City was opened as a pilot site for “Resbakuna sa Botika.” QualiMed Clinic – Makati and Healthway Multi-Specialty Center – Manila will also open their doors on January 21, as pilot clinic sites to priority groups who want to avail of COVID-19 vaccine shots.

During this week-long program, each of the branches will be allocated 500 doses of COVID-19 vaccines by their partner LGUs. Individuals 18 years old and above – except for senior citizens and people with comorbidities – can pre-register, in coordination with their LGU, and avail of their shots.  

“We are grateful for another opportunity to partner with the government to make vaccines even more accessible to our fellow Filipinos,” said Paolo Borromeo, President & CEO of AC Health.

“The ‘Resbakuna sa Botika’ is an important initiative to refocus our vaccination strategy as a country. By expanding vaccinations to pharmacies and even clinics, we can make it more convenient for people to get their vaccines. We believe this model will be a good strategy to ensure continued access to vaccines in the future, and we look forward to having more of our drugstores and clinics as vaccination sites,” Borromeo added.

AC Health, through its COVIDShield Program, has administered over 660,000 doses of the COVID-19 vaccine in its more than 30 vaccination sites across the country. MedEthix, a member of AC Health, was the first to bring Molnupiravir in the Philippines and Southeast Asia. Molnupiravir is an oral anti-viral treatment for mild cases of COVID-19 among high-risk adult populations, and is now available upon prescription across the AC Health Network – through Healthway, QualiMed and HealthNow.

###

AC Health

Ayala Healthcare Holdings, Inc. (AC Health) is a wholly-owned subsidiary of the Ayala Corporation, and serves as the portfolio company for healthcare businesses. Its vision is to build an ecosystem that links every patient to a seamless healthcare experience. Its portfolio includes Generika Drugstore, the pioneer in generic retail pharmacies, IE Medica and MedEthix, major pharmaceutical importer and distributor, Healthway, a network of primary care, multi-specialty, and corporate clinics, and QualiMed, a comprehensive network of full-service hospitals, multi-specialty clinics, and a stand-alone day surgery center. AC Health has also invested in health technology solutions, most recently, HealthNow, a healthcare aggregator app that offers online consultations, medicine delivery, and clinic and diagnostic booking.

For further inquiries, contact:

Nicole Tajanlangit
Strategy and External Affairs
E-mail: ztajanlangit.ncb@achealth.com.ph